Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

SJ, how much do you think they should

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
too simple Member Profile
 
Followed By 3
Posts 420
Boards Moderated 0
Alias Born 09/29/14
160x600 placeholder
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002 GlobeNewswire Inc. - 11/19/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 7:12:10 AM
Bio-Path Holdings Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/13/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:12:44 PM
Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020 GlobeNewswire Inc. - 11/6/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/5/2020 4:25:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/5/2020 4:20:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:31:22 PM
Bio-Path Receives Notice of Allowance for Strategic Patent for Prexigebersen in Combination with Front Line Cytidine Analogue... GlobeNewswire Inc. - 10/22/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2020 4:17:35 PM
Bio-Path Holdings to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Bio-Path Holdings Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/14/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2020 4:31:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 4:12:37 PM
Bio-Path Holdings Announces First Patient Dosed in Amended Stage 2 of the Phase 2 Clinical Trial Evaluating Prexigebersen in ... GlobeNewswire Inc. - 8/13/2020 7:00:10 AM
Bio-Path Holdings to Announce Second Quarter 2020 Financial Results on August 14, 2020 GlobeNewswire Inc. - 8/7/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/14/2020 8:20:52 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/14/2020 8:19:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2020 4:48:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2020 4:16:42 PM
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting GlobeNewswire Inc. - 5/29/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 7:17:29 AM
Bio-Path Holdings Reports First Quarter 2020 Financial Results GlobeNewswire Inc. - 5/15/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:31:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 4:12:24 PM
too simple   Tuesday, 07/09/19 10:42:24 AM
Re: SJSTOCKSHARK post# 6165
Post # of 6304 
SJ, how much do you think they should raise ? Would they sell the shares on the open ? It’s been so long I am not even sure what we are waiting on anymore .

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences